These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer. Cui L; Wang Y; Shi Y; Zhang Z; Xia Y; Sun H; Wang S; Chen J; Zhang W; Lu Q; Song L; Wei Q; Zhang R; Wang X Proteomics; 2007 Nov; 7(22):4192-202. PubMed ID: 17994624 [TBL] [Abstract][Full Text] [Related]
17. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. Sanchez-Carbayo M; Socci ND; Lozano J; Saint F; Cordon-Cardo C J Clin Oncol; 2006 Feb; 24(5):778-89. PubMed ID: 16432078 [TBL] [Abstract][Full Text] [Related]
18. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions]. Sibony M; Billerey C Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498 [TBL] [Abstract][Full Text] [Related]
19. Molecular alterations associated with bladder cancer progression. Sánchez-Carbayo M; Cordon-Cardó C Semin Oncol; 2007 Apr; 34(2):75-84. PubMed ID: 17382791 [TBL] [Abstract][Full Text] [Related]
20. Searching for novel therapeutics and targets: insights from clinical trials. Mitra AP; Cote RJ Urol Oncol; 2007; 25(4):341-3. PubMed ID: 17628305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]